Candidate Biomarkers Identified for Psoriasis Progression
FRIDAY, May 20, 2022 -- Candidate biomarkers for disease progression in psoriasis have been identified, according to a review published online April 28 in the British Journal of Dermatology. Ravi Ramessur, B.M.B.S., from King ' s College London, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2022 Category: Pharmaceuticals Source Type: news

Risk for Ectopic Pregnancy Increased for Women With Psoriasis
WEDNESDAY, May 18, 2022 -- Women with psoriasis have a significantly increased risk for ectopic pregnancy (EP), which is highest for those with moderate-to-severe psoriasis, according to a study published in the June issue of JAAD... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 18, 2022 Category: Pharmaceuticals Source Type: news

New Data Show TREMFYA ® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
SPRING HOUSE, PENNSYLVANIA, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA® (guselkumab) from risankizumab due to the ability of TREMFYA to bind to CD64 positive (CD64+) cells in addition to interleukin (IL)-23 — both of which are key components of the immune system. 1,2 These findings, which are being presented at the Society for Investigative Dermatology (SID) annual meeting May 18-21, 2022 in Portland, Oregon, demonstrate TREMFYA bind...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

What is in the Differential Diagnosis for Black and White Skin Conditions?
Discussion This is the third in a short case series of differential diagnoses of colored skin conditions. An introduction to dermatological terminologies and information about colors can be can be found here. A differential diagnosis by distribution and common pattern can be found here. For red, orange and yellow conditions, a review can be found here. For green, blue and purple conditions, a review can be found here. For brown and grey conditions, a review can be found here. Note that any color can be a normal variant for an individual or is physiologic for a given state. When lesions of the opposite color of the normal s...
Source: PediatricEducation.org - May 9, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Episode 3: Topical Prescribing Tips for Better Psoriasis Outcomes Episode 3: Topical Prescribing Tips for Better Psoriasis Outcomes
Dermatologists Steven Feldman and Melinda Gooderham share expert advice and go-to options for topical use in patients with psoriasis.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 5, 2022 Category: Consumer Health News Tags: Dermatology InDiscussion Source Type: news

Bimekizumab for Moderate-to-severe Plaque Psoriasis Bimekizumab for Moderate-to-severe Plaque Psoriasis
Bimekizumab, which selectively inhibits both interleukin-17A and IL-17F, is currently under investigation for treatment of moderate-to-severe psoriasis. What is the best dosing interval?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

What's the best remedy for a flaky, itchy scalp? DR MARTIN SCURR answers your health questions 
DR MARTIN SCURR: Psoriasis is a chronic inflammatory disorder that typically causes a build-up of flaky patches on the skin - the result of a speeding up of the production of skin cells. (Source: the Mail online | Health)
Source: the Mail online | Health - May 3, 2022 Category: Consumer Health News Source Type: news

Parents' Autoimmune Diseases May Affect Children's Development Parents' Autoimmune Diseases May Affect Children's Development
Type 1 diabetes and psoriasis in parents are associated with an increased risk for autism spectrum disorder and attention-deficit/hyperactivity disorder in children, data indicate.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 29, 2022 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

TV ads, social media may fuel growing psoriasis drug market in U.S.
Anybody in the United States who watches television knows about the skin condition psoriasis -- and the commercials they see may be contributing to a rise in psoriasis diagnoses, experts say. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 26, 2022 Category: Consumer Health News Source Type: news

Two-Year Data for Ixekizumab in Pediatric Psoriasis Reported Two-Year Data for Ixekizumab in Pediatric Psoriasis Reported
More than half of patients had achieved 100% clearance with the IL-17 inhibitor at 2 years.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 25, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

What is in the Differential Diagnosis for Red, Orange or Yellow Skin Conditions?
Discussion This is the first in a short case series of differential diagnoses of colored skin conditions. A differential diagnosis by distribution and common pattern can be found here. For green, blue and violet conditions, a review can be found here. For black and white conditions, a review can be found here. For brown and grey conditions, a review can be found here. Note that any color can be a normal variant for an individual or is physiologic for a given state. The skin is the largest organ of the body. It can be easily examined but for many clinicians continues to be difficult to describe what they are seeing. Analo...
Source: PediatricEducation.org - April 25, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Lifestyle Factors Are Predictive of Incident Psoriasis
WEDNESDAY, April 20, 2022 -- Lifestyle factors are predictive of the risk for incident psoriasis, regardless of genetic risk, according to a study published online April 12 in the Journal of the American Academy of Dermatology. Minxue Shen, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2022 Category: Pharmaceuticals Source Type: news

Johnson & Johnson Reports Q1 2022 Results
New Brunswick, N.J. (April 19, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2022. “Our first quarter results demonstrate strong performance across the enterprise, despite macro-economic headwinds. I am incredibly proud of Johnson & Johnson’s 144,000 employees for their relentless passion and Credo-based commitment to delivering transformative healthcare solutions to patients and customers around the world,” said Joaquin Duato, Chief Executive Officer. “Looking ahead, I remain confident in the future of Johnson & Johnson as we continue advancing our portfolio and inno...
Source: Johnson and Johnson - April 19, 2022 Category: Pharmaceuticals Tags: Financial Source Type: news

Long-term Safety of Risankizumab in Plaque Psoriasis Long-term Safety of Risankizumab in Plaque Psoriasis
The safety findings in this analysis support risankizumab as a long-term treatment option for patients with moderate-to-severe psoriasis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 18, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Picture of Psoriasis 2
Title: Picture of Psoriasis 2Category: ImagesCreated: 12/16/2010 1:42:00 PMLast Editorial Review: 4/18/2022 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - April 18, 2022 Category: Dermatology Source Type: news